APPLICATION
NDA018790
TYPE
NDA
ORIGINAL APPROVAL
1983-10-06
LATEST ACTION
1998-12-01
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
FUROSEMIDEDiscontinued
FUROSEMIDE 40MG · TABLET · ORAL
Approval history
1998-12-01Manufacturing (CMC) · Supplement 37AP
1994-12-23Manufacturing (CMC) · Supplement 36AP
1994-10-11Manufacturing (CMC) · Supplement 35AP
1993-08-17Labeling · Supplement 34AP
1992-08-11Labeling · Supplement 33AP
1992-05-01Labeling · Supplement 32AP
1992-04-03Manufacturing (CMC) · Supplement 29AP
1992-04-03Manufacturing (CMC) · Supplement 31AP
1991-04-02Labeling · Supplement 28AP
1991-02-05Manufacturing (CMC) · Supplement 27AP
1991-02-05Manufacturing (CMC) · Supplement 25AP
1989-05-10Labeling · Supplement 26AP
1989-02-24Manufacturing (CMC) · Supplement 22AP
1989-02-24Manufacturing (CMC) · Supplement 23AP
1989-02-24Manufacturing (CMC) · Supplement 21AP
1988-12-22Labeling · Supplement 24AP
1988-02-24Manufacturing (CMC) · Supplement 17AP
1987-12-10Manufacturing (CMC) · Supplement 19AP
1987-07-27Manufacturing (CMC) · Supplement 18AP
1986-12-12Manufacturing (CMC) · Supplement 14AP
1986-12-12Manufacturing (CMC) · Supplement 13AP
1986-01-07Manufacturing (CMC) · Supplement 12AP
1985-10-21Manufacturing (CMC) · Supplement 11AP
1985-06-28Manufacturing (CMC) · Supplement 10AP
1985-06-28Manufacturing (CMC) · Supplement 9AP
1983-10-06OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.